Core Cap Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $58 - $80	5 New	5 $0
Q2 2022 Aug 11, 2022	BUY	$11.23 - $19.59 $56 - $97	5 New	5 $0
Q1 2022 Apr 29, 2022	SELL	$13.37 - $17.79 $66 - $88	-5 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.28 - $19.53 $71 - $97	5 New	5 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.